• TRADE NAMES: Aphilan; Bucladin-S; Buclixin; Longifene; Odetin; Postafeno; Vibazina; Vibazine
  • INDICATIONS: Motion sickness, nausea/vomiting
  • CLASS: Histamine H1 receptor antagonist
  • HALF-LIFE: N/A

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric